-
Dr Dan Gooding, Nuformix, increasingly confident US regulators will grant NXP002 Orphan Drug Status
15 Oct 2025 03:39 GMT
… programme NXP002 has been granted Orphan Drug Designation in Idiopathic Pulmonary Fibrosis … US regulators will also grant orphan drug status and what that would …
-
Orphan Drugs Service Market to Reach US $80.62 Billion by 2029
14 Oct 2025 00:00 GMT
… yields through regulatory incentives like orphan drug classification, market exclusivity, and reduced … In The Global Orphan Drugs Service Market Report?
The orphan drugs service market covered …
-
ReviR Therapeutics Receives Orphan Drug Designation from FDA for RTX-117 to Treat Charcot-Marie-Tooth Disease
13 Oct 2025 10:57 GMT
… Administration (FDA) has granted Orphan Drug Designation (ODD) for … .
The FDA’s Orphan Drug Designation program is a … therapeutic intervention. Receiving Orphan Drug Designation for RTX-117 … 47;revir-therapeutics-receives-orphan-drug-designation-from-fda-for …
-
<![CDATA[FDA Grants Orphan Drug Designation to Cintredekin Besudotox in Glioblastoma]]>
10 Oct 2025 22:41 GMT
… glioblastoma.1
“Receiving orphan drug designation is an important … The FDA has granted orphan drug designation to cintredekin …
Precision NeuroMed granted FDA orphan drug designation by U.S … ;precisionneuromed.com/fda-orphan-drug-designation-for-gbm…
-
Head of FDA's orphan drug office is removed from role
10 Oct 2025 22:40 GMT
-
Trinity Capital Inc. Provides $130 Million in Growth Capital to Candel Therapeutics, Supporting Development of Viral Immunotherapies to Fight Cancer
14 Oct 2025 12:39 GMT
… , and dual Fast Track and Orphan Drug designations for both its pancreatic … -to-high-risk disease and Orphan Drug Designation to CAN-2409 for … received Fast Track Designation and Orphan Drug Designation from the FDA. Finally …
-
Immix Biopharma to Present at the Guggenheim 2nd Annual Healthcare Innovation Conference
14 Oct 2025 12:45 GMT
… ) by the US FDA and Orphan Drug Designation (ODD) by FDA and …
-
Cellectar Biosciences Presented Promising Preclinical Data in Poster Presentation at the American Association for Cancer Research (AACR) Special Conference on Pancreatic Cancer Research
14 Oct 2025 12:30 GMT
… I 131 Breakthrough Designation, six Orphan Drug, four Rare Pediatric Drug and … ) has also granted PRIME and orphan drug designations for the treatment of …
-
Candel Therapeutics Enters into $130 Million Term Loan Facility with Trinity Capital Inc.
14 Oct 2025 12:10 GMT
… both Fast Track Designation and Orphan Drug Designation to CAN-2409 for … received Fast Track Designation and Orphan Drug Designation from the FDA. Today …
-
Candel Therapeutics Announces Positive Interim Data After Repeated Administration of CAN-3110 in Recurrent Glioblastoma and Announces Publication in Science Translational Medicine
14 Oct 2025 12:05 GMT
… FDA Fast Track Designation and Orphan Drug Designation for the treatment of … both Fast Track Designation and Orphan Drug Designation to CAN-2409 for … received Fast Track Designation and Orphan Drug Designation from the FDA for …